News
COVID-19: NAFDAC Receives Dossiers For Chinese Vaccine, Others For Evaluation – Minister
- He identified the COVID-19 vaccines as Sinopharm Vaccine of China, Sputnik V vaccine of Russia, Covishield or Astra Zeneca
The National Agency for Food and Drug Administration and Control (NAFDAC) has received dossiers for Chinese vaccine and three others for evaluation amid the ravaging COVID-19 pandemic in the country.
This is according to the Minister of Health, Osagie Ehanire, who addressed reporters in Abuja on Monday during a briefing by the Presidential Task Force (PTF) on COVID-19.
He identified the COVID-19 vaccines as Sinopharm Vaccine of China, Sputnik V vaccine of Russia, Covishield or Astra Zeneca manufactured under license by Serum Institute of India and Covaxin by Bharat vaccines of India.
Read also: Nigerians Consume 587 Million Condoms Annually – Report
“The National Agency For Drug Administration and Control (NAFDAC) has received dossiers for Sputnik V vaccine of Russia, Covishield or Astra Zeneca manufactured under license by Serum Institute of India, Covaxin by Bharat vaccines of India and the Sinopharm Vaccine of China, for evaluation and validation for use in Nigeria. Some of them are nearly ready for results,” he said.
“It is important to stress that all covid19 vaccines carry a certain amount of risk and any vaccines not approved by the Federal Ministry of Health through its Agencies cannot be used in Nigeria.
“The government will not be responsible for the safety or efficacy of vaccines given outside the framework of the Government. All the needs of Nigeria have been carefully calculated by NPHCDA and it is possible to accommodate all interests in the framework.”
The Minister also announced the donation of 100,000 AstraZeneca or covishield vaccine doses by the Indian government.
YOU MAY ALSO LIKE
- Lagos Seals Event Centres, Night Clubs For Violating COVID-19 Protocols
- Okonjo-Iweala Will Excel In Her New Role As WTO Head – Buhari
Advertise or Publish a Story on EkoHot Blog:
Kindly contact us at [email protected]. Breaking stories should be sent to the above email and substantiated with pictorial evidence.
Citizen journalists will receive a token as data incentive.
Call or Whatsapp: 0803 561 7233, 0703 414 5611
